Literatür
- Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe (STI231026)
- Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023)
- Prospective Analysis of Febrile Neutropenia Patients with Bacteremia: The Results of ID-IRI Study (IJA230707)
- General Practitioners' Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey (Vaccines230615)
- Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic Inpatients (CID200114)
- Comparative Diagnostic of Cervical Tuberculous Lymphadenitis: PCR is a Fast, Efficient, and Improved Diagnostic Approach (CJID230613)
- A New Global Definition of Acute Respiratory Distress Syndrome (AJRCCM230724)
- Determinants and outcomes of bloodstream infections related to obesity (Ejcmid221004)
- Comparison between culture positive and negative septic shock in patients in the ED (220915)
- Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study (NMNI220907)
- Initiating ART within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe PCP (BMC220805)
- Oral Fluoroquinolone Use and the Risk of Acute Liver Injury: A Nationwide Cohort Study (CID220706)
- Analysis of an ASP for Asymptomatic Bacteriuria in the Veterans Affairs Health Care System (Jama220701)
- Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the AHA (Circulation220831)
- The Evaluation of the Factors Affecting Mortality in Cases of HIV-infected Pneumocystis Jiroveci Pneumonia (Klimik191213)
- The Epidemiological, Clinical, Mycological, and Pathological Features of Rhino-cerebral Mucormycosis (IJP220308)
- TB screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis (Lancet220323)
- Staphylococcus aureus small-colony variants: Formation, infection, and treatment (MR220701)
- Chronic Granulomatous Disease (GR220421)
- Pulmonary Manifestations of Primary Humoral Deficiencies (CRJ220410)
- Antibiyotik sonrası çağda İYE'nin tanısal ve antimikrobiyal yönetimi (CMI220528)
- Yüksek vücut ağırlığı olanlarda yüksek doz sefazolin'in güvenliği ve etkinliği (Ofid220404)
- Çift karbapenem kombinasyonunun karbapenem dirençli Gram negatif bakterilere karşı etkinliği (Spj220314)
- Kriptokokal menenjitte tek doz lipozomal Amfoterisin B tedavisi (Nejm220324)
- 15 ülkede nedeni bilinmeyen şiddetli hepatit: Patoloji bir ipucu sunuyor mu? (Idsa220429)
- Enterobacterales kan dolaşımı enfeksiyonları tedavisinde 7-14 günlük tedavi süreleri benzer (Cmı220428)
- Paradoksal tüberküloz ilişkili IRIS'in önlenmesi için prednizon (Nejm181115)
- Kritik hastalarda Gram-negatif bakteri enfeksiyonları için seftazidim/avibaktamın çok merkezli çalışması (Ijaa220303)
- Temiz otopedik cerrahi sonrası antimikrobiyal profilaksi süresinin sağlık bakımı ilişkili enfeksiyonlara etkisi (Jama220412)
- Uzun süreli entekavir tedavisi sırasında gizli HBV enfeksiyonunun reaktivasyonu (Front.Microbiol.220310)
- CREDIBLE-CR ve APEKS-NP faz 3 randomize çalışmalarda MBL infeksiyonların tedavisinde Sefiderokol (CID220211)
- The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations (Antibiotics220212)
- Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of CR A. baumannii (Pharmaceutics211224)
- Prior Carriage Predicts ICUs Caused by ESBL–Producing Enterobacteriaceae (AJTMH220110)
- Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed (AAC220110)
- Effectiveness of ceftazidime-avibactam for the treatment of infections due to P. aeruginosa (IJAA220103)
- Beta-lactam monotherapy or combination therapy for BSIs or pneumonia due to P. aeruginosa: a meta-analysis (IJAA211228)
- Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia (OFID211217)
- A nationwide population-based study of E. coli BSIs: incidence, antimicrobial resistance and mortality (CMI211215)
- ESCMID guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (CMI211215)
- Prediction of mortality in S. aureus BSI using quick Pitt bacteremia score (211209)
- Aminoglycoside or Polymyxin Monotherapy for Treating Complicated UTIs Caused by XDR P. aeruginosa (IDT211203)
- The role of new carbapenem combinations in the treatment of MDR Gram-negative infections (JAC211121)
- Antimicrobial-Resistant Gram-Negative Infections: Version 2.0 (IDSA211122)
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for MDR and VDR A. baumannii infections: A systematic review and network meta-analysis (Jgar210324)
- Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing Enterobacterales Using Time-Kill Assays (AAC210318)
- Impact of a Multiplex PCR Panel on Duration of Empiric Antibiotic Therapy in Suspected Bacterial Meningitis (OFID211001)
- MDR Gram-negatif bakteriyel enfeksiyonları tedavisinde iv polimiksin B'nin klinik kullanımı (Jgar210101)
- HIV hastalarında CMV hastalığının saptanmasında tam kanda antijenemi ve qPCR cut-off değerlerinin standardizasyonu (Rsbmt190601)
- A.baumannii enfeksiyonunda tek başına/kombine kolistinin güvenliği ve etkinliği: Sistematik derleme ve meta-analiz (Ijaa190401)